Telenor to acquire the rest of DNA shares through the tender offer.

Telenor made mandatory public cash tender offer to acquire all of the issued and outstanding shares in DNA that are not held by DNA or any of its group companies or by the Offeror or any of its group companies for €20.90 ($23.50) per Share. The initially scheduled offer period of the Tender Offer expired on 26 September 2019. According to the final results of the Initial Offer Period of the Tender Offer, Telenor acquired 40% of all the shares in DNA. Now Telenor stakes represent 94% of all the shares in DNA. The settlement of the completion trades for the Initial Offer Period is expected to take place on 2 October 2019. “I am very pleased to announce today’s transaction and our entry into Finland, the fastest growing mobile market in Europe. DNA is an exciting addition to Telenor Group, and a natural complement to our existing operations in the Nordic region. Not only are we strengthening our footprint in the Nordic region, we are also gaining a solid position across fixed and mobile in the Finnish market and making room for further value creation." Sigve Brekke, Telenor Group Chief Executive.